Glutamate cysteine ligase (GCL) catalyzes the rate-limiting step in the formation of the cellular antioxidant glutathione (GSH). The GCL holoenzyme consists of two separately coded proteins, a catalytic subunit (GCLC) and a modifier subunit (GCLM). Both GCLC and GLCM are controlled transcriptionally by a variety of cellular stimuli, including oxidative stress. This study addresses post-translational control of GCL activity, which increased rapidly in human lymphocytes following oxidative stress. Activation of GCL occurred within minutes of treatment and without any change in GCL protein levels and coincided with an increase in the proportion of GCLC in the holoenzyme form. Likewise, GCLM shifted from the monomeric form to holoenzyme and higher molecular weight species. Normal rat tissues also showed a distribution of monomeric and higher molecular weight forms. Neither GCL activation, nor the formation of holoenzyme, required a covalent intermolecular disulfide bridge between GCLC and GCLM. However, in immunoprecipitation studies, a neutralizing epitope associated with enzymatic activity was protected following cellular oxidative stress. Thus, the N-terminal portion of GCLC may undergo a change that stabilizes the GCL holoenzyme. Our results suggest that a dynamic equilibrium exists between low and high activity forms of GCL and is altered by transient oxidative stress. This provides a mechanism for the rapid post-translational activation of GCL and maintenance of cellular GSH homeostasis.The tripeptide glutathione (GSH) is the major low molecular weight cellular thiol. Reduced GSH is present in most cell types at millimolar concentrations, whereas the oxidized forms glutathione disulfide (GSSG) 2 and mixed disulfides are ϳ100-fold less abundant in the cytosol. GSH plays a role in myriad cellular functions, including maintenance of reduced protein thiols, detoxification of hydrogen peroxide (H 2 O 2 ) and lipid peroxides, secondary metabolism, and non-enzymatic scavenging of free radicals (1). GSH also protects against apoptotic cell death following exposure to antineoplastic agents, radiation, and receptor-based death signals (2-6). The initial step in GSH synthesis is catalyzed by glutamate cysteine ligase (GCL), a heterodimeric enzyme with a 73-kDa catalytic subunit (GCLC) and a 31-kDa modifier subunit (GCLM) (7,8). GCL generates the dipeptide ␥-glutamyl cysteine in a reaction requiring ATP; the second, non-rate-limiting step in GSH formation is the addition of glycine by GSH synthetase. GCLC contains the glutamate, cysteine, and ATP binding sites and has catalytic activity as a monomer. However, compared with the GCLC subunit alone, the GCL holoenzyme has enhanced V max , increased glutamate and ATP binding affinity, and reduced feedback inhibition by GSH, which competes at the Glu binding site (7, 9). Thus, the GCL holoenzyme has efficient activity over a larger range of cellular conditions, with kinetics that favor activity under physiological glutamate and ATP concentrations.A model widely cited in the GC...